Pulmonary Hypertension and Thyroid Disease Management in COPD Patients

Diagnostic Evaluation

• The European Respiratory Society recommends a complete blood count, BNP or NT-proBNP, comprehensive metabolic panel, troponin, iron studies, and arterial blood gas analysis for the initial assessment of pulmonary hypertension in COPD patients 1, 2, 4
• Echocardiography is recommended to evaluate right ventricular systolic pressure, right and left ventricular function, pericardial effusion, and right atrial size in patients with suspected pulmonary hypertension 1, 2, 3, 5
• A six-minute walk test with Borg dyspnea score is recommended for objective functional assessment in patients with pulmonary hypertension 1, 2, 3
• Pulmonary function tests with DLCO are recommended to characterize COPD severity and exclude restrictive lung disease 5
• High-resolution chest CT is recommended to evaluate parenchymal lung disease and exclude chronic thromboembolic disease 5
• Ventilation-perfusion scan is mandatory to exclude chronic thromboembolic pulmonary hypertension, as this is potentially surgically correctable 5, 6

Specialty Consultations and Follow-up

• The American College of Cardiology recommends cardiology consultation if echocardiography shows significant pulmonary hypertension or right ventricular dysfunction 3, 5
• Pulmonology consultation is recommended for COPD optimization and pulmonary hypertension management 3, 5
• Endocrinology consultation is recommended if thyroid dysfunction is confirmed or nodules require intervention 3
• Reassessing patients within 2-4 weeks after initial testing is recommended to review results and determine if specialty referral is needed 3